Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Regeneron Pharmaceuticals, Inc. company logo
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc. (REGN)

Summary

As of today, REGN price is $826.64, down -1.69% on
REGN price is currently -31.75% below its historical high of $1,211.20 set on
REGN current market cap is $85B, up +35.34% over the past 365 days
REGN current PE ratio is 20.43
REGN current annual revenue is $14.34B, up +0.99% year-over-year
The next earnings release for REGN is on

Profile

Company profile for Regeneron Pharmaceuticals, Inc. (REGN)
MetricValue
Full NameRegeneron Pharmaceuticals, Inc.
TickerNASDAQ: REGN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
Indexes
Websiteregeneron.com
Employees15,182

Key Metrics

Regeneron Pharmaceuticals, Inc. Key Details
MetricValueDate
Price$826.64
Price, 1D Change-1.69%
Market Cap$85B
TTM Dividend Yield0.45%
PE Ratio20.43
Beta0.47
Revenue$14.34B
Revenue, 1Y Change+0.99%
EPS$41.48
EPS, 1Y Change+8.20%

Chart

SUGGESTED SERIES
Regeneron Pharmaceuticals, Inc. chart

Events

Regeneron Pharmaceuticals, Inc. Events
MetricValueDate
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-Dividend$0.94
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

REGN Estimates
MetricValueDate
EPS$41.48
EPS Estimate$53.01N/A
EPS Est. Change+27.78%N/A
Revenue$14.34B
Revenue Estimate$16.89BN/A
Revenue Est. Change+17.75%N/A
Current Price$826.64
Price Target$808.57-
Price Tgt. Change-2.19%-

🔒 Log In To Unlock Full Data

EPS

REGN EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$44.92$38.34-14.66%
$43.16$41.48-3.88%
$53.01N/A+27.78%
$50.40N/A+21.50%
REGN EPS reported versus estimate values chart

Revenue

REGN revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$14.16B$14.20B+0.29%
$14.22B$14.34B+0.89%
$16.89BN/A+17.75%
$18.34BN/A+27.87%
REGN revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

REGN Performance
MetricValueDate
Price, 1Y+39.87%
Price, 3Y+1.75%
Market Cap, 1Y+35.34%
Market Cap, 3Y-3.80%
Revenue, 1Y+0.99%
Revenue, 3Y+17.83%
EPS, 1Y+8.20%
EPS, 3Y+8.52%

🔒 Log In To Unlock Full Data

Technicals

REGN Technical Indicators
MetricValueDate
Current Price$826.64
SMA 200$723.49
SMA 50$691.62
EMA 200$702.01
EMA 50$724.67
MACD$39.45
Beta0.47
ATR$20.26
14-Day RSI75.18
10-Day Volatility27.64%

Dividends

REGN Dividends
MetricValueDate
Last Paid$0.94
UpcomingN/AN/A
Dividend Yield0.53%
Total Dividend$4.40
$370.30M
8.22%

🔒 Log In To Unlock Full Data

Income & Profitability

REGN Income & Profitability
MetricValueDate
Revenue$14.34B
EPS$41.48
Gross Profit$12.37B
Gross Margin86.27%
Operating Income$3.69B
Operating Margin25.75%
Net Income$4.50B
Net Margin31.41%
EBITDA$4.25B

🔒 Log In To Unlock Full Data

Financial Health

REGN Financial Health
MetricValueDate
Debt To Equity0.09
4.77
4.22
-
7
8.03

Valuations

REGN Valuations
MetricValueDate
PE Ratio20.43
5.48
2.68
16.97
-N/A

Balance Sheet

REGN Balance Sheet
MetricValueDate
Book Value$31.26B
$8.61B
$40.56B
$27.81B
$9.30B
$5.83B
Total Debt$2.97B
$37.80M
$939.00M

Expenses

REGN Expenses
MetricValueDate
$9.84B
$8.68B
$2.64B
$2.70B
$543.70M
$0.00
$725.80M

Cash Flow

REGN Cash Flow
MetricValueDate
$4.98B
-$629.10M
-$3.72B
Capex$1.21B
$3.77B

Recent analyst updates

REGN Recent analyst updates
MetricValueDate
Guggenheim→
Citigroup→
Wells Fargo→
Truist Securities→
RBC Capital→
Morgan Stanley→
Cantor Fitzgerald→
Guggenheim→
Piper Sandler→
Morgan Stanley→

Analyst sentiment

Sentiment over the past month
REGN analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
REGN institutional ownership distribution chart

Screeners with REGN

FAQ

What is the ticker symbol for Regeneron Pharmaceuticals, Inc.?
The ticker symbol for Regeneron Pharmaceuticals, Inc. is NASDAQ:REGN
Does Regeneron Pharmaceuticals, Inc. pay dividends?
Yes, Regeneron Pharmaceuticals, Inc. pays dividends. The last payment was $0.94, with an ex-dividend date on August 18, 2026
What sector is Regeneron Pharmaceuticals, Inc. in?
Regeneron Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Regeneron Pharmaceuticals, Inc. in?
Regeneron Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Regeneron Pharmaceuticals, Inc. based in?
Regeneron Pharmaceuticals, Inc. is headquartered in United States
When did Regeneron Pharmaceuticals, Inc. go public?
Regeneron Pharmaceuticals, Inc. initial public offering (IPO) was on April 2, 1991
Is Regeneron Pharmaceuticals, Inc. in the S&P 500?
Yes, Regeneron Pharmaceuticals, Inc. is included in the S&P 500 index
Is Regeneron Pharmaceuticals, Inc. in the NASDAQ 100?
Yes, Regeneron Pharmaceuticals, Inc. is included in the NASDAQ 100 index
Is Regeneron Pharmaceuticals, Inc. in the Dow Jones?
No, Regeneron Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Regeneron Pharmaceuticals, Inc. last earnings report?
Regeneron Pharmaceuticals, Inc.'s most recent earnings report was on July 30, 2026
When does Regeneron Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Regeneron Pharmaceuticals, Inc. is October 28, 2026

Data Sources & References

  1. REGN Official Website www.regeneron.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm
  3. List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
  4. List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
  5. REGN Profile on Yahoo Finance finance.yahoo.com/quote/REGN
  6. REGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/regn